Cell Therapy Raw Materials Market Forecast Highlights Expansion From $6.1 Billion To $12.74 Billion Through 2030
Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
Cell Therapy Raw Materials Market CAGR Analysis And Future Market Development
The market for raw materials used in cell therapy has experienced remarkable expansion over the past few years, with its value projected to climb from $5.07 billion in 2025 to $6.1 billion in 2026, reflecting a compound annual growth rate (CAGR) of 20.4%. This upward trajectory in the historical period was driven by several factors, including the early-stage development of cell therapies, a heavy dependence on animal-derived sera, constraints on scaling up cell culture processes, a rise in academic and clinical investigations focused on cell therapy, and heightened investment flowing into regenerative medicine.
The cell therapy raw materials sector is anticipated to undergo significant expansion over the coming years. Projections indicate it will reach a value of $12.75 billion by 2030, driven by a compound annual growth rate (CAGR) of 20.2%. This anticipated rise during the forecast period stems from factors such as the commercialization of cell and gene therapies, a growing need for CAR-T treatments, improvements in materials used for cell expansion and cryopreservation, heightened regulatory demands concerning raw material quality, and the scaling up of biopharmaceutical manufacturing capacity. Key developments shaping this period include a growing need for consistent, high-quality cell culture media, a shift toward serum-free and chemically defined raw materials, an expanding pipeline for CAR-T and gene therapy production, a rise in outsourcing to specialized material suppliers, and an intensified focus on meeting regulatory standards and ensuring traceability.
Download A Free Sample Report For Comprehensive Market Insights:
Cell Therapy Raw Materials Market Demand Drivers: What Is Fueling Industry Growth?
The rising application of regenerative medicine is anticipated to boost the cell therapy raw materials market in the coming years. Regenerative medicine is a medical field focused on restoring or establishing normal function by replacing, engineering, or regenerating human cells, tissues, or organs. Its adoption is accelerating due to the increasing prevalence of chronic and degenerative diseases, as these conditions create a demand for therapies that repair or replace damaged tissues rather than merely alleviating symptoms. Cell therapy raw materials support advancements in regenerative medicine by supplying critical components like growth factors, cell culture media, enzymes, and scaffolds, which are necessary for cultivating, expanding, and maintaining therapeutic cells used to repair or regenerate damaged tissues and organs. For example, the National Library of Medicine, a U.S.-based biomedical repository, reported in January 2025 that 32 new gene therapies, including genetically modified cell therapies, had received approval in 2024. Consequently, the expanding use of regenerative medicine is fueling growth in the cell therapy raw materials market.
Cell Therapy Raw Materials Market Segmentation And Category Breakdown
The cell therapy raw materials market covered in this report is segmented –
1) By Therapy Area: Stem Cell Based Raw Materials, Gene Therapy Raw Materials, CAR-T Cell Therapy Raw Materials
2) By Product Type: Media, Sera, Cell Culture Supplements, Antibodies, Reagents And Buffers, Other Product Types
3) By End User: Biopharmaceutical And Pharmaceutical Companies, Contract Research Organization And Contract Manufacturing Organization, Other End Users
Subsegments:
1) By Stem Cell Based Raw Materials: Growth Factors, Cytokines, Cell Culture Media
2) By Gene Therapy Raw Materials: Transfection Reagents, Nucleotides And Enzymes, Cell Culture Media For Gene Modification
3) By Car-T Cell Therapy Raw Materials: T Cell Activation Reagents, Cell Expansion Media, Cryopreservation Agents
Cell Therapy Raw Materials Market Innovation Trends: Which Developments Are Transforming The Industry?
Major key players within the cell therapy raw materials market are actively prioritizing the creation of novel solutions, particularly through good manufacturing practice (GMP)-compliant manufacturing, aimed at guaranteeing product safety, uniformity, and adherence to regulatory standards across the cell therapy production workflow. The concept of GMP-compliant manufacturing involves a framework designed to ensure that products are consistently generated and managed in line with quality benchmarks established by regulatory bodies, thereby minimizing risks inherent in pharmaceutical and biotechnological production. As an example, in April 2025, Thermo Fisher Scientific Inc., a US-based enterprise specializing in life sciences and clinical research, unveiled an advanced therapies collaboration center (ATxCC) in the US to facilitate the development and market introduction of cell and gene therapies. This facility expedites cell therapy development by delivering comprehensive cGMP manufacturing assistance, state-of-the-art technologies, and expert process refinement. It encourages collaborative efforts aimed at addressing manufacturing obstacles and accelerating the path to commercialization.
Cell Therapy Raw Materials Market Competitive Analysis Of Major Industry Participants
Major companies operating in the cell therapy raw materials market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Lonza Group AG, Sartorius Stedim Biotech SA, Bio-Techne Corporation, Stemcell Technologies Inc., Miltenyi Biotec GmbH, ACROBiosystems Co Ltd., CellGenix GmbH, Promocell GmbH, RoosterBio Inc., Akron Biotech LLC.
Access The Complete Cell Therapy Raw Materials Market Report:
Cell Therapy Raw Materials Market Regional Analysis: Which Region Leads By Revenue?
North America was the largest region in the cell therapy raw materials market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell therapy raw materials market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
